ERAP1 gene expression is influenced by nonsynonymous polymorphisms associated with predisposition to spondyloarthritis

Arthritis and Rheumatology

Volumn 67, Issue 6, 2015, Pages 1525-1534

  Costantino, Félicie ^a,b   Talpin, Alice ^a   Evnouchidou, Irini ^c   Kadi, Amir ^a   Leboime, Ariane ^b   Said Nahal, Roula ^b   Bonilla, Nelly ^a   Letourneur, Franck ^d   Leturcq, Tifenn ^a   Ka, Zeyna ^a   Van Endert, Peter ^c   Garchon, Henri Jean ^a,b   Chiocchia, Gilles ^a   Breban, Maxime ^a,b  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

^c INSTITUT NECKER ENFANTS MALADES   (France)

^d INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; MESSENGER RNA; UNCLASSIFIED DRUG; ERAP1 PROTEIN, HUMAN;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE PREDISPOSITION; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; FRANCE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPONDYLARTHRITIS; WESTERN BLOTTING; ANKYLOSING SPONDYLITIS; CASE CONTROL STUDY; COHORT ANALYSIS; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; PROTECTION; SPONDYLOARTHROPATHY;

ADULT; AMINOPEPTIDASES; BLOTTING, WESTERN; CASE-CONTROL STUDIES; COHORT STUDIES; DENDRITIC CELLS; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; PROTECTIVE FACTORS; RNA, MESSENGER; SPONDYLARTHROPATHIES; SPONDYLITIS, ANKYLOSING;

EID: 84929891993     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39072     Document Type: Article

References (50)

1. Costantino F, Talpin A, Said-Nahal R, Goldberg M, Henny J, Chiocchia G, et al., Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort. Ann Rheum Dis 2015; 74: 689-93.
2. Said-Nahal R, Miceli-Richard C, Berthelot JM, Duche A, Dernis-Labous E, Le Blevec G, et al, on behalf of Groupe Français d'Etude Génétique des Spondylarthropathies. The familial form of spondylarthropathy: a clinical study of 115 multiplex families [published erratum appears in Arthritis Rheum 2000; 43:2140]. Arthritis Rheum 2000; 43: 1356-65.
3. Said-Nahal R, Miceli-Richard C, D'Agostino MA, Dernis-Labous E, Berthelot JM, Duche A, et al, on behalf of Groupe Français d'Etude Génétique des Spondylarthropathies. Phenotypic diversity is not determined by independent genetic factors in familial spondylarthropathy. Arthritis Rheum 2001; 45: 478-84.
4. Breban M, Miceli-Richard C, Zinovieva E, Monnet D, Said-Nahal R., The genetics of spondyloarthropathies. Joint Bone Spine 2006; 73: 355-62.
5. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, et al., Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007; 39: 1329-37.
6. Maksymowych WP, Inman RD, Gladman DD, Reeve JP, Pope A, Rahman P., Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis. Arthritis Rheum 2009; 60: 1317-23.
7. Tsui FW, Haroon N, Reveille JD, Rahman P, Chiu B, Tsui HW, et al., Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis. Ann Rheum Dis 2010; 69: 733-6.
8. Davidson SI, Wu X, Liu Y, Wei M, Danoy PA, Thomas G, et al., Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum 2009; 60: 3263-8.
9. Kadi A, Izac B, Said-Nahal R, Leboime A, van Praet L, de Vlam K, et al., Investigating the genetic association between ERAP1 and spondyloarthritis. Ann Rheum Dis 2013; 72: 608-13.
10. Cherciu M, Popa LO, Bojinca M, Dutescu MI, Bojinca V, Bara C, et al., Functional variants of ERAP1 gene are associated with HLA-B27 positive spondyloarthritis. Tissue Antigens 2013; 82: 192-6.
11. Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, et al., Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011; 43: 761-7.
12. International Genetics of Ankylosing Spondylitis Consortium (IGAS), Cortes A, Hadler J, Pointon JP, Robinson PC, Karaderi T, et al., Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet 2013; 45: 730-8.
13. Saric T, Chang SC, Hattori A, York IA, Markant S, Rock KL, et al., An IFN-γ-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat Immunol 2002; 3: 1169-76.
14. York IA, Chang SC, Saric T, Keys JA, Favreau JM, Goldberg AL, et al., The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol 2002; 3: 1177-84.
15. Cui X, Hawari F, Alsaaty S, Lawrence M, Combs CA, Geng W, et al., Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. J Clin Invest 2002; 110: 515-26.
16. Cui X, Rouhani FN, Hawari F, Levine SJ., An aminopeptidase, ARTS-1, is required for interleukin-6 receptor shedding. J Biol Chem 2003; 278: 28677-85.
17. Cui X, Rouhani FN, Hawari F, Levine SJ., Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding. J Immunol 2003; 171: 6814-9.
18. Haroon N, Tsui FW, Chiu B, Tsui HW, Inman RD., Serum cytokine receptors in ankylosing spondylitis: relationship to inflammatory markers and endoplasmic reticulum aminopeptidase polymorphisms. J Rheumatol 2010; 37: 1907-10.
19. Harvey D, Pointon JJ, Evans DM, Karaderi T, Farrar C, Appleton LH, et al., Investigating the genetic association between ERAP1 and ankylosing spondylitis. Hum Mol Genet 2009; 18: 4204-12.
20. Bettencourt BF, Rocha FL, Alves H, Amorim R, Caetano-Lopes J, Vieira-Sousa E, et al., Protective effect of an ERAP1 haplotype in ankylosing spondylitis: investigating non-MHC genes in HLA-B27-positive individuals. Rheumatology (Oxford) 2013; 52: 2168-76.
21. Kochan G, Krojer T, Harvey D, Fischer R, Chen L, Vollmar M, et al., Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc Natl Acad Sci U S A 2011; 108: 7745-50.
22. Goto Y, Hattori A, Ishii Y, Tsujimoto M., Reduced activity of the hypertension-associated Lys528Arg mutant of human adipocyte-derived leucine aminopeptidase (A-LAP)/ER-aminopeptidase-1. FEBS Lett 2006; 580: 1833-8.
23. Evnouchidou I, Kamal RP, Seregin SS, Goto Y, Tsujimoto M, Hattori A, et al., Coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic peptide generation in vitro by influencing basic enzymatic properties of the enzyme. J Immunol 2011; 186: 1909-13.
24. Reeves E, Edwards CJ, Elliott T, James E., Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity. J Immunol 2013; 191: 35-43.
25. Seregin SS, Rastall DP, Evnouchidou I, Aylsworth CF, Quiroga D, Kamal RP, et al., Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens. Autoimmunity 2013; 46: 497-508.
26. Nguyen TT, Chang SC, Evnouchidou I, York IA, Zikos C, Rock KL, et al., Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1. Nat Struct Mol Biol 2011; 18: 604-13.
27. Hacquard-Bouder C, Falgarone G, Bosquet A, Smaoui F, Monnet D, Ittah M, et al., Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy. Arthritis Rheum 2004; 50: 1624-35.
28. Hacquard-Bouder C, Chimenti MS, Giquel B, Donnadieu E, Fert I, Schmitt A, et al., Alteration of antigen-independent immunologic synapse formation between dendritic cells from HLA-B27-transgenic rats and CD4+ T cells: selective impairment of costimulatory molecule engagement by mature HLA-B27. Arthritis Rheum 2007; 56: 1478-89.
29. Glatigny S, Fert I, Blaton MA, Lories RJ, Araujo LM, Chiocchia G, et al., Proinflammatory Th17 cells are expanded and induced by dendritic cells in spondylarthritis-prone HLA-B27-transgenic rats. Arthritis Rheum 2012; 64: 110-20.
30. Utriainen L, Firmin D, Wright P, Cerovic V, Breban M, McInnes I, et al., Expression of HLA-B27 causes loss of migratory dendritic cells in a rat model of spondylarthritis. Arthritis Rheum 2012; 64: 3199-209.
31. Araujo LM, Fert I, Jouhault Q, Labroquere K, Andrieu M, Chiocchia G, et al., Increased production of interleukin-17 over interleukin-10 by Treg cells implicates inducible costimulator molecule in experimental spondyloarthritis. Arthritis Rheumatol 2014; 66: 2412-22.
32. Talpin A, Costantino F, Bonilla N, Leboime A, Letourneur F, Jacques S, et al., Monocyte-derived dendritic cells from HLA-B27+ axial spondyloarthritis (SpA) patients display altered functional capacity and deregulated gene expression. Arthritis Res Ther 2014; 16: 417.
33. Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, et al., The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009; 68: 777-83.
34. Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT, et al., The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011; 70: 25-31.
35. Barrett JC, Fry B, Maller J, Daly MJ., Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5.
36. Gautier L, Cope L, Bolstad BM, Irizarry RA., affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004; 20: 307-15.
37. Monks SA, Leonardson A, Zhu H, Cundiff P, Pietrusiak P, Edwards S, et al., Genetic inheritance of gene expression in human cell lines. Am J Hum Genet 2004; 75: 1094-105.
38. Martin-Esteban A, Gomez-Molina P, Sanz-Bravo A, Lopez de Castro JA., Combined effects of ankylosing spondylitis-associated ERAP1 polymorphisms outside the catalytic and peptide-binding sites on the processing of natural HLA-B27 ligands. J Biol Chem 2014; 289: 3978-90.
39. Haroon N, Tsui FW, Uchanska-Ziegler B, Ziegler A, Inman RD., Endoplasmic reticulum aminopeptidase 1 (ERAP1) exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in ankylosing spondylitis. Ann Rheum Dis 2012; 71: 589-95.
40. Dixon AL, Liang L, Moffatt MF, Chen W, Heath S, Wong KC, et al., A genome-wide association study of global gene expression. Nat Genet 2007; 39: 1202-7.
41. Ding J, Gudjonsson JE, Liang L, Stuart PE, Li Y, Chen W, et al., Gene expression in skin and lymphoblastoid cells: refined statistical method reveals extensive overlap in cis-eQTL signals. Am J Hum Genet 2010; 87: 779-89.
42. Fairfax BP, Makino S, Radhakrishnan J, Plant K, Leslie S, Dilthey A, et al., Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nat Genet 2012; 44: 502-10.
43. Garnier S, Truong V, Brocheton J, Zeller T, Rovital M, Wild PS, et al., Genome-wide haplotype analysis of cis expression quantitative trait loci in monocytes. PLoS Genet 2013; 9: e1003240.
44. Campbell EC, Fettke F, Bhat S, Morley KD, Powis SJ., Expression of MHC class I dimers and ERAP1 in an ankylosing spondylitis patient cohort. Immunology 2011; 133: 379-85.
45. Goto Y, Ogawa K, Hattori A, Tsujimoto M., Secretion of endoplasmic reticulum aminopeptidase 1 is involved in the activation of macrophages induced by lipopolysaccharide and interferon-γ. J Biol Chem 2011; 286: 21906-14.
46. Fruci D, Ferracuti S, Limongi MZ, Cunsolo V, Giorda E, Fraioli R, et al., Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines. J Immunol 2006; 176: 4869-79.
47. Garcia-Medel N, Sanz-Bravo A, van Nguyen D, Galocha B, Gomez-Molina P, Martin-Esteban A, et al., Functional interaction of the ankylosing spondylitis-associated endoplasmic reticulum aminopeptidase 1 polymorphism and HLA-B27 in vivo. Mol Cell Proteomics 2012; 11: 1416-29.
48. Garcia-Medel N, Sanz-Bravo A, Alvarez-Navarro C, Gomez-Molina P, Barnea E, Marcilla M, et al., Peptide handling by HLA-B27 subtypes influences their biological behavior, association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1). Mol Cell Proteomics 2014; 13: 3367-80.
49. Akram A, Lin A, Gracey E, Streutker CJ, Inman RD., HLA-B27, but not HLA-B7, immunodominance to influenza is ERAP dependent. J Immunol 2014; 192: 5520-8.
50. Marcilla M, Lopez de Castro JA., Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis. Tissue Antigens 2008; 71: 495-506.